←
Sebastian Stintzing148 posts
Sebastian Stintzing avatar

Sebastian Stintzing

@StintzingS

Specialist for Hematology and Medical Oncology at Charité Universitaetsmedizin Berlin

◷ Joined February 2018▧ 4 Photos and videos
Sebastian Stintzing avatar
Sebastian Stintzing@StintzingS·29 Dec 2025

Finally out! The Basis for Future Personalized Therapy Approaches - Machine Learning-Generated 1-Year Survival Rate, Metastatic Status and Therapy-dependent Survival in Pancreatic Cancer Patients - European Journal of Cancer ejcancer.com/article/S0959-8…

Sebastian Stintzing avatar
Sebastian Stintzing@StintzingS·5 Feb 2025

Baseline Liquid Biopsy in Relation to Tissue-Based Parameters in Metastatic Colorectal Cancer: Results From the Randomized FIRE-4 (AIO-KRK-0114) Study | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JCO…

Sagittarius EU Project avatar
⟳ Sebastian Stintzing retweeted
Sagittarius EU Project@sagittarius_eu_·16 Jan 2025

The SAGITTARIUS clinical trial will use personalised liquid biopsy tests to personalise the management & therapy of patients with high-risk stage II or operable stage III colon cancer. It will include 4 experimental arms. More: sagittarius-horizon.eu/

Post attachment
Kathrin Heinrich avatar
⟳ Sebastian Stintzing retweeted
Kathrin Heinrich@heinrich_kat·29 May 2024

Nothing to add here… @Prof_Nadia_H is a huge role model and will an amazing @myESMO president! Vote now ‼️ esmo.org/about-esmo/how-we-w…

Dear Friends I wholeheartedly Support Prof. Nadia Harbeck🇩🇪 @Prof_Nadia_H for President of @myESMO 2027-2028 ✅Strong Advocate for Women in Oncology ✅Focus on future Generations ✅Vision of Inclusion and Diversity ✅ESMO Lifetime Achievement Award Link esmo.org/about-esmo/how-we-w…

1:16
Kathrin Heinrich avatar
⟳ Sebastian Stintzing retweeted
Kathrin Heinrich@heinrich_kat·15 Nov 2023

Tomorrow the @OncoAlert 🚨 Newsletter will be out! There are some really 🔥 news, so if you don’t receive it yet, there is still time to sign up! Especially important in my opinion are the @ASCO guidelines on drug shortages in #oncology ‼️

OncoAlert@OncoAlert15 Nov 2023

The @OncoAlert 🚨Newsletter OUT TOMORROW November 16, 2023 REGISTER AT: OncoAlert360.com Covering: ✅🔑🫁🌊KEYNOTE 564 in#RCC ✅PACIFIC2 in #NSCLC ✅TALAPRO2 EMA recommendation of Talazoparib + Enzalutamide ✅Drug Shortages in Oncology: @ASCO ✅Clinical Guidance Lessons from ADAURA📷 by @JackWestMD @n8pennell ✅Severe Immune-Related Enteritis after In Utero Exposure to Pembrolizumab and more @ChristianRolfo @GlopesMd @StephenVLiu @bmassutis @Tony_Calles @s_couraud @CharuAggarwalMD @christine_lovly @jillfeldman4 @ivybelkins @bensolomon1 @VanitaNoronha @DrSanjayPopat @JulienMazieres @TerriConneran @montypal @crisbergerot @DrDanielHeng @apolo_andrea @DrChoueiri @PGrivasMDPhD @TiansterZhang @HHammersMD @ravikanesvaran @neerajaiims @amerseburger @sonpavde @drenriquegrande @scserendipity1 @tompowles1 @DrYukselUrun @JournalCancer #OncoAlertAF @nataliagandur @acampsmalea @MartaPerachino @heinrich_kat @yekeduz_emre @HHorinouchi @FadiHaddad_MD @Dr_Ivanoncologo @DrYukselUrun @FuenteApolo @Abdallah81MD

0:10